Veranova's Technical Development team in Edinburgh was delighted to welcome 35 students from the Universiteit van Amsterdam (University of Amsterdam) for an afternoon on-site visit! After being provided with an overview of Veranova, our guests were introduced to the capabilities of our Edinburgh site, including products and associated process chemistry, a process chemistry workshop, and lab and plant tours.
Veranova
Pharmaceutical Manufacturing
Devens, Massachusetts 19,560 followers
A CDMO that manages complexity with confidence
About us
Veranova is a global leader in process development and manufacturing of active pharmaceutical ingredients (APIs), with a focus on specialty and complex chemistry for small molecules, antibody-drug conjugates, oligonucleotides and peptides. Veranova is headquartered in Devens, Massachusetts and has operations in North America and Europe. For more information, please visit www.veranova.com.
- Website
-
https://www.veranova.com
External link for Veranova
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Devens, Massachusetts
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
25 Patton Road
Devens, Massachusetts 01434, US
Employees at Veranova
Updates
-
In today's installment of #PharmorphixFix, Veranova's Associate Principal Scientist, Jade Owen, explains how the Analytical Services team developed a fit-for-purpose solution for an unusual drug compound. Without a UV chromophore, the compound was challenging to monitor, but Veranova found a solution in just one week. Read more below.
-
Curious about antibody-drug conjugates? In a recent article with Pharma Focus America, Veranova's Associate Director, VaraPrasad Chandrabatla, Ph.D, explored techniques to develop #ADCs safely. Read the article in full below.
𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚𝐥 𝐓𝐞𝐜𝐡𝐧𝐢𝐪𝐮𝐞𝐬 𝐟𝐨𝐫 𝐀𝐧𝐭𝐢𝐛𝐨𝐝𝐲-𝐃𝐫𝐮𝐠 𝐂𝐨𝐧𝐣𝐮𝐠𝐚𝐭𝐞𝐬: 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐢𝐧𝐠 𝐂𝐥𝐚𝐫𝐢𝐭𝐲 𝐚𝐧𝐝 𝐂𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐜𝐞 𝐭𝐨 𝐂𝐚𝐧𝐜𝐞𝐫 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 Dive into the world of antibody-drug conjugates (ADCs) with insights from VaraPrasad Chandrabatla, Ph.D., 𝑨𝒔𝒔𝒐𝒄𝒊𝒂𝒕𝒆 𝑫𝒊𝒓𝒆𝒄𝒕𝒐𝒓 at Veranova. ADCs are transforming cancer therapy by combining the precision of monoclonal antibodies with potent cytotoxic drugs, minimizing harm to healthy tissues. Key analytical techniques like HPLC and mass spectrometry are crucial for ADC characterization, ensuring their efficacy and stability. Discover the innovations and challenges in #ADCdevelopment and manufacturing that are shaping the future of cancer therapeutics. 𝐋𝐞𝐚𝐫𝐧 𝐡𝐨𝐰 𝐫𝐨𝐛𝐮𝐬𝐭 𝐚𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐀𝐈 𝐚𝐧𝐝 𝐦𝐮𝐥𝐭𝐢-𝐨𝐦𝐢𝐜𝐬 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡𝐞𝐬, 𝐚𝐫𝐞 𝐞𝐧𝐬𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐜𝐨𝐧𝐬𝐢𝐬𝐭𝐞𝐧𝐜𝐲 𝐨𝐟 𝐀𝐃𝐂𝐬: https://lnkd.in/g88_Ecxk #ADC #cancerresearch #pharmaceuticals #analyticalchemistry #biopharmaceuticals #targetedtherapy #antibodydrugconjugates #cancertherapy #pharmaceuticalinnovation #targetedcancertreatment #veranova
-
-
Day 2 of CPHI Americas has begun, and Veranova's experts are thrilled to be spending another day discussing all things #Pharma in Philadelphia, PA. Take a look below for some event highlights, and make sure to visit our experts at Booth 536 until May 22: https://lnkd.in/gqDcGEPT #CPHIAmericas
-
-
#DYK Veranova worked with over 280 clients last year? Leveraging our extensive expertise, we are proud to help our partners meet their #DrugDevelopment and #API manufacturing needs. Contact us today to find out how we can accelerate your project: https://lnkd.in/gqDcGEPT
-
-
Our Edinburgh site was delighted to host a group of Supply Chain Operations Management students and their lecturer Dr. Aboozar Jamalnia from the Edinburgh Napier University Business School recently. The visit was an interactive one-stop shop which covered site introductions from VP and General Manager, David Payne, followed by site tours of key production and supply chain operations activities. They were also provided with an oversight of our S&OP process, continuous improvement basics and quality and compliance insights. We look forward to welcoming more student visits in the future!
-
-
The Veranova team is looking forward to heading to Bio2Business Ltd’s BOS Basel 2025. For biotech companies, crystallization control is critical to achieving the optimal solid form with the required particle properties — and it’s often a complex challenge. To explore how to overcome these hurdles, join Ruth Lunt, Senior Scientist at Veranova, on June 11th at 4.20 PM (CEST) for her presentation: “From Vials to Vessels: Discovery and Development in the Salt / Cocrystal Continuum” See you in Basel.
-
-
This week, we are participating in #LearningatWorkWeek at our site in Cambridge. Run by Campaign for Learning, which encourages life-long learning through resources and events, the week is an opportunity to #GetConnected by working on our communication and team skills. We have also started to complete our Manual of Me, a tool for exploring how we work best with others. Using this, we hope to improve team dynamics by understanding our own preferences and motivations and how to best showcase them. By exploring different learning paths and taking part in an emotional intelligence and personality workshop, our team members will be making a difference to their day-to-day and long-term goals.
-
-
Veranova is delighted to announce the appointment of Elizabeth Rebeil as Global Vice President of Supply Chain and Operational Excellence. With more than 20 years of experience in supply chain management and continuous improvement within the pharmaceutical, life sciences, and manufacturing industries, Elizabeth’s expertise will be instrumental to Veranova as it continues to optimize its global operations. Read in full: https://lnkd.in/gzsHex-t
-
-
#ICYMI, Veranova's Scientist I, Jethro Beamish-Cook, discussed methods for improving poor solubility during #DrugDevelopment in a recent webinar. Watch the webinar on demand now to find out how crystalline nanosuspensions can help enhance the solubility and bioavailability of drug molecules: https://lnkd.in/guwzpAiM
-